Comparing asthma control assessment using the Asthma Control Test and the Asthma APGAR in African American/Black and Hispanic/Latinx populations.

Autor:	Yawn BP; Department of Family and Community Health, University of Minnesota, Minneapolis, MN, USA., Ericson B; Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, MA, USA., Cui J; Division of Rheumatology, Inflammation and Immunity, Brigham and Women's Hospital, Boston, MA, USA., Israel E; Divisions of Pulmonary and Critical Care Medicine and Allergy & Immunology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Maher N; Divisions of Pulmonary and Critical Care Medicine and Allergy & Immunology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Pace W; Department of Family Medicine, University of Colorado, Aurora, CO, USA., Fuhlbrigge A; Pulmonary Sciences and Critical Care Medicine, Department of Medicine, University of Colorado School of Medicine, Aurora, CO, USA.
Jazyk:	angličtina
Zdroj:	The Journal of asthma : official journal of the Association for the Care of Asthma [J Asthma] 2023 Aug; Vol. 60 (8), pp. 1592-1600. Date of Electronic Publication: 2023 Feb 02.
DOI:	10.1080/02770903.2022.2164201
Abstrakt:	Introduction: The objective of this analysis was to compare the Asthma Control Test (ACT) and the Asthma APGAR asthma control assessment tools in African-Ancestry/Black (AA/B) and Hispanic/Latinx (H/L) adults with moderate to severe asthma. Methods: This pre-planned sub-study of the PREPARE clinical trial compares the baseline ACT and Asthma APGAR scores for the PREPARE populations using correlation coefficients, generalized linear modeling and receiver operating curve (ROC) analyses. Correlations were also assessed for both control tests and the Asthma Symptom Utility Index (ASUI). Results: Among the 1201 adults (603 AA/B and 598 H/L) with moderate to severe asthma, most had uncontrolled asthma by both the ACT and the Asthma APGAR. Correlation coefficients between the ACT, Asthma APGAR and ASUI were strong and did not differ significantly by race/ethnicity. The ACT consistently assessed more patients as uncontrolled compared with the Asthma APGAR. The differences in ACT and Asthma APGAR scores did not differ by age, gender, race/ethnicity, self-reported health literacy or medication adherence but did differ by education level. Both the ACT and Asthma APGAR had similar ROCs for predicting an asthma exacerbation in the next 3 months. Conclusions: Both the ACT and the Asthma APGAR can be used for asthma control assessment in AA/B and H/L populations with moderate to severe asthma, providing comparable rates of uncontrolled asthma and similar limited ability to predict exacerbations. Further work is required to better understand the basis and clinical implications of the higher rates of uncontrolled asthma identified using the ACT.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu